Glutathione-responsive Nanoparticles for Optimized Cas9/sgRNA Gene Editing Delivery

References

1. Liu F. Ma F. Wang Y. Hao L. Zeng H. Jia C. Wang Y. Liu P. Ong I.M. Li B. Chen G. Jiang J. Gong S. Li L. Xu W. PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis. Nat. Cell Biol. 2017 19 11 1358 1370 10.1038/ncb3630 29058718
   [Google Scholar]
2. Maqbool M. Hussain M.S. Shaikh N.K. Sultana A. Bisht A.S. Agrawal M. Noncoding RNAs in the COVID-19 Saga: An untold story. Viral Immunol. 2024 37 6 269 286 10.1089/vim.2024.0026 38968365
   [Google Scholar]
3. Xie F. Wang M. Chen Q. Chi T. Zhu S. Wei P. Yang Y. Zhang L. Li X. Liao Z. Endogenous stimuli-responsive nanoparticles for cancer therapy: From bench to bedside. Pharmacol. Res. 2022 186 106522 10.1016/j.phrs.2022.106522 36283629
   [Google Scholar]
4. Wang M. Zuris J.A. Meng F. Rees H. Sun S. Deng P. Han Y. Gao X. Pouli D. Wu Q. Georgakoudi I. Liu D.R. Xu Q. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proc. Natl. Acad. Sci. USA 2016 113 11 2868 2873 10.1073/pnas.1520244113 26929348
   [Google Scholar]
5. Liu J Chang J Jiang Y Meng X Sun T Mao L Fast and efficient CRISPR/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles. Adv Mater. 2019 31 e1902575 10.1002/adma.201902575.
   [Google Scholar]
6. Chen G. Ma B. Wang Y. Gong S. A universal GSH-responsive nanoplatform for the delivery of DNA, mRNA, and Cas9/sgRNA ribonucleoprotein. ACS Appl. Mater. Interfaces 2018 10 22 18515 18523 10.1021/acsami.8b03496 29798662
   [Google Scholar]
7. Chen G. Abdeen A.A. Wang Y. Shahi P.K. Robertson S. Xie R. Suzuki M. Pattnaik B.R. Saha K. Gong S. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing. Nat. Nanotechnol. 2019 14 10 974 980 10.1038/s41565‑019‑0539‑2 31501532
   [Google Scholar]
8. Khan Y. Hussain M.S. Ramalingam P.S. Fatima R. Maqbool M. Ashique S. Khan N.U. Bisht A.S. Gupta G. Exploring extracellular RNA as drivers of chemotherapy resistance in cancer. Mol. Biol. Rep. 2025 52 1 142 10.1007/s11033‑025‑10263‑2 39836259
   [Google Scholar]
9. Ling X. Tu J. Wang J. Shajii A. Kong N. Feng C. Zhang Y. Yu M. Xie T. Bharwani Z. Aljaeid B.M. Shi B. Tao W. Farokhzad O.C. Glutathione-responsive prodrug nanoparticles for effective drug delivery and cancer therapy. ACS Nano 2019 13 1 357 370 10.1021/acsnano.8b06400 30485068
   [Google Scholar]
10. Ding H. Zhou C. Li T. Nanomedicines with Versatile GSH-responsive linkers for cancer theranostics. ACS Biomater. Sci. Eng. 2024 10 10 5977 5994 10.1021/acsbiomaterials.4c00897 39298132
    [Google Scholar]
11. Hussain S. Gupta G. Shahwan M. Bansal P. Kaur H. Deorari M. Pant K. Ali H. Singh S.K. Rama Raju Allam V.S. Paudel K.R. Dua K. Kumarasamy V. Subramaniyan V. Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of ferroptosis. Noncoding RNA Res. 2024 9 4 1222 1234 10.1016/j.ncrna.2024.05.007 39036600
    [Google Scholar]
12. Sahel DK Vora LK Saraswat A Sharma S Monpara J D'Souza AA CRISPR/Cas9 genome editing for tissue-specific in vivo targeting: Nanomaterials and translational perspective. Adv Sci (Weinh). 2023 10 19 e2207512 10.1002/advs.202207512.
    [Google Scholar]
13. Huang S. Xu Z. Zhi W. Li Y. Hu Y. Zhao F. Zhu X. Miao M. Jia Y. pH/GSH dual-responsive nanoparticle for auto-amplified tumor therapy of breast cancer. J. Nanobiotechnology 2024 22 1 324 10.1186/s12951‑024‑02588‑0 38858692
    [Google Scholar]
14. Yuan Y. Nie T. Fang Y. You X. Huang H. Wu J. Stimuli-responsive cyclodextrin-based supramolecular assemblies as drug carriers. J. Mater. Chem. B Mater. Biol. Med. 2022 10 13 2077 2096 10.1039/D1TB02683F 35233592
    [Google Scholar]
15. Huang Y. Moini Jazani A. Howell E.P. Oh J.K. Moffitt M.G. Controlled microfluidic synthesis of biological stimuli-responsive polymer nanoparticles. ACS Appl. Mater. Interfaces 2020 12 1 177 190 10.1021/acsami.9b17101 31820915
    [Google Scholar]
16. Su H. Rong G. Li L. Cheng Y. Subcellular targeting strategies for protein and peptide delivery. Adv. Drug Deliv. Rev. 2024 212 115387 10.1016/j.addr.2024.115387 38964543
    [Google Scholar]
17. Iqbal Z. Rehman K. Xia J. Shabbir M. Zaman M. Liang Y. Duan L. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing. Biomater. Sci. 2023 11 11 3762 3783 10.1039/D2BM01636B 37102700
    [Google Scholar]
18. Cleal K. He L. Watson P.D. Jones A.T. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles. Curr. Pharm. Des. 2013 19 16 2878 2894 10.2174/13816128113199990297 23140451
    [Google Scholar]